{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:08:38Z","timestamp":1791295718236,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1023\/b:caco.0000007973.59863.66","type":"journal-article","created":{"date-parts":[[2003,12,13]],"date-time":"2003-12-13T13:10:55Z","timestamp":1071321055000},"page":"915-922","source":"Crossref","is-referenced-by-count":44,"title":["Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast"],"prefix":"10.1007","volume":"14","author":[{"given":"Patricia G.","family":"Moorman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet M.","family":"Grubber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Millikan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"5149905_CR1","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1146\/annurev.med.51.1.511","volume":"51","author":"JA Baron","year":"2000","unstructured":"Baron JA,Sandler RS (2000) Nonsteroidal anti-inflammatory drugs and cancer prevention. Annu Rev Med\n51: 511-523.","journal-title":"Annu Rev Med"},{"key":"5149905_CR2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/94.4.252","volume":"94","author":"MJ Thun","year":"2002","unstructured":"Thun MJ,Henley SJ,Patrono C (2002) Nonsteroidal antiinflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst\n94: 252-266.","journal-title":"J Natl Cancer Inst"},{"key":"5149905_CR3","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2165\/00003495-200262060-00006","volume":"62","author":"K Jolly","year":"2002","unstructured":"Jolly K,Cheng KK,Langman MJ (2002) NSAIDs and gastrointestinal cancer prevention. Drugs\n62: 945-956.","journal-title":"Drugs"},{"key":"5149905_CR4","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1054\/bjoc.2000.1709","volume":"84","author":"SA Khuder","year":"2001","unstructured":"Khuder SA,Mutgi AB (2001) Breast cancer and NSAID use: a meta-analysis. Br J Cancer\n84: 1188-1192.","journal-title":"Br J Cancer"},{"key":"5149905_CR5","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1136\/bmj.299.6710.1247","volume":"299","author":"A Paganini-Hill","year":"1989","unstructured":"Paganini-Hill A,Chao A,Ross RK,Henderson BE (1989) Aspirin use and chronic diseases: a cohort study of the elderly. BMJ\n299: 1247-1250.","journal-title":"BMJ"},{"key":"5149905_CR6","first-page":"1322","volume":"53","author":"MJ Thun","year":"1993","unstructured":"Thun MJ,Namboodiri MM,Calle EE,Flanders WD,Heath CW Jr (1993) Aspirin use and risk of fatal cancer. Cancer Res\n53: 1322-1327.","journal-title":"Cancer Res"},{"key":"5149905_CR7","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/jnci\/88.14.988","volume":"88","author":"KM Egan","year":"1996","unstructured":"Egan KM,Stampfer MJ,Giovannucci E,Rosner BA,Colditz GA (1996) Prospective study of regular aspirin use and the risk of breast cancer. J Natl Cancer Inst\n88: 988-993.","journal-title":"J Natl Cancer Inst"},{"key":"5149905_CR8","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1136\/bmj.320.7250.1642","volume":"320","author":"MJS Langman","year":"2000","unstructured":"Langman MJS,Cheng KK,Gilman EA,Lancashire RJ (2000) Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. BMJ\n320: 1642-1646.","journal-title":"BMJ"},{"key":"5149905_CR9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00001648-199403000-00003","volume":"5","author":"DM Schreinemachers","year":"1994","unstructured":"Schreinemachers DM,Everson RB (1994) Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology\n5: 138-146.","journal-title":"Epidemiology"},{"key":"5149905_CR10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/pmed.1995.1022","volume":"24","author":"RE Harris","year":"1995","unstructured":"Harris RE,Namboodiri K,Stellman SD,Wynder EL (1995) Breast cancer and NSAID use: heterogeneity of effect in a case-control study. Prev Med\n24: 119-120.","journal-title":"Prev Med"},{"key":"5149905_CR11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00001648-199603000-00017","volume":"7","author":"RE Harris","year":"1996","unstructured":"Harris RE,Namboodiri KK,Farrar WB (1996) Nonsteroidal antiinflammatory drugs and breast cancer. Epidemiology\n7: 203-205.","journal-title":"Epidemiology"},{"key":"5149905_CR12","first-page":"71","volume":"6","author":"RE Harris","year":"1999","unstructured":"Harris RE,Kasbari S,Farrar WB (1999) Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer. Oncol Rep\n6: 71-73.","journal-title":"Oncol Rep"},{"key":"5149905_CR13","first-page":"869","volume":"7","author":"AI Neugut","year":"1998","unstructured":"Neugut AI,Rosenberg DJ,Ahsan H, et al. (1998) Association between coronary heart disease and cancers of the breast, prostate, and colon. Cancer Epidemiol Biomarkers Prev\n7: 869-873.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5149905_CR14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1006\/pmed.1999.0518","volume":"29","author":"PF Coogan","year":"1999","unstructured":"Coogan PF,Rao S,Rosenberg L, et al. (1999) The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer. Prev Med\n29: 72-76.","journal-title":"Prev Med"},{"key":"5149905_CR15","first-page":"1213","volume":"10","author":"M Cotterchio","year":"2001","unstructured":"Cotterchio M,Kreiger N,Sloan M,Steingart A (2001) Nonsteroidal anti-inflammatory drug use and breast cancer risk. Cancer Epidemiol Biomarkers Prev\n10: 1213-1217.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5149905_CR16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1054\/bjoc.2000.1119","volume":"83","author":"CR Sharpe","year":"2000","unstructured":"Sharpe CR,Collet J-P,McNutt M,Belzile E,Boivin J-F,Hanley JA (2000) Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage. Br J Cancer\n83: 112-120.","journal-title":"Br J Cancer"},{"key":"5149905_CR17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF00694745","volume":"35","author":"B Newman","year":"1995","unstructured":"Newman B,Moorman PG,Millikan R, et al. (1995) The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat\n35: 51-60.","journal-title":"Breast Cancer Res Treat"},{"key":"5149905_CR18","first-page":"307","volume":"14","author":"PG Moorman","year":"2003","unstructured":"Moorman PG,Grubber JM,Millikan RC,Newman B (2003) Antidepressant medications and their association with invasive breast cancer and carcinoma in situ of the breast. Epidemiology\n14: 307-314.","journal-title":"Epidemiology"},{"key":"5149905_CR19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/oxfordjournals.aje.a116104","volume":"134","author":"CR Weinberg","year":"1991","unstructured":"Weinberg CR,Sandler DP (1991) Randomized recruitment in case-control studies. Am J Epidemiol\n134: 421-432.","journal-title":"Am J Epidemiol"},{"key":"5149905_CR20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/abbi.2000.2232","volume":"387","author":"M Ouellet","year":"2001","unstructured":"Ouellet M,Percival MD (2001) Mechanism of acetaminophen inhibition of cyclooxygenase isoforms. Arch Biochem Biophys\n387: 273-280.","journal-title":"Arch Biochem Biophys"},{"key":"5149905_CR21","first-page":"1377","volume":"7","author":"GA Alshafie","year":"2000","unstructured":"Alshafie GA,Abou-Issa HM,Seibert K,Harris RE (2000) Chemotherapeutic evaluation of celecoxib, a cyclooxygenase-2 inhibitor, in a rat mammary tumor model. Oncol Rep\n7: 1377-1381.","journal-title":"Oncol Rep"},{"key":"5149905_CR22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/jnci\/90.6.455","volume":"90","author":"D Hwang","year":"1998","unstructured":"Hwang D,Scollard D,Byrne J,Levine E (1998) Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst\n90: 455-460.","journal-title":"J Natl Cancer Inst"},{"key":"5149905_CR23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1023\/A:1005924730450","volume":"48","author":"EK Han","year":"1998","unstructured":"Han EK,Arber N,Yamamoto H, et al. (1998) Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines. Breast Cancer Res Treat\n48: 195-203.","journal-title":"Breast Cancer Res Treat"},{"key":"5149905_CR24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1023\/A:1006993631057","volume":"19","author":"P Glue","year":"1999","unstructured":"Glue P,Clement RP (1999) Cytochrome P450 enzymes and drug metabolism-basic concepts and methods of assessment. Cell Mole Neurobiol\n19: 309-323.","journal-title":"Cell Mole Neurobiol"},{"key":"5149905_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.39.1.1","volume":"39","author":"FP Guengerich","year":"1999","unstructured":"Guengerich FP (1999) Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol\n39: 1-17.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"5149905_CR26","first-page":"950","volume":"60","author":"C Guillemette","year":"2000","unstructured":"Guillemette C,Millikan RC,Newman B,Housman DE (2000) Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African-Americans. Cancer Res\n60: 950-956.","journal-title":"Cancer Res"},{"key":"5149905_CR27","first-page":"3566","volume":"61","author":"J Bigler","year":"2001","unstructured":"Bigler J,Whitton J,Lampe JW,Fosdick L,Bostick RM,Potter JD (2001) CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk. Cancer Res\n61: 3566-3569.","journal-title":"Cancer Res"},{"key":"5149905_CR28","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00008571-199612000-00006","volume":"6","author":"SJ London","year":"1996","unstructured":"London SJ,Daly AK,Leathart JB,Navidi WC,Idle JR (1996) Lung cancer risk in relation to the CYP2C9 * 1\/CYP2C9 * 2 genetic polymorphism among African-Americans and Caucasians in Los Angeles County, California. Pharmacogenetics\n6: 527-533.","journal-title":"Pharmacogenetics"},{"key":"5149905_CR29","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1001\/jama.1978.03290200060025","volume":"240","author":"RA Monson","year":"1978","unstructured":"Monson RA,Bond CA (1978) The accuracy of the medical record as an index of outpatient drug therapy. JAMA\n240: 2182-2184.","journal-title":"JAMA"},{"key":"5149905_CR30","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/oxfordjournals.aje.a112529","volume":"107","author":"PD Stolley","year":"1978","unstructured":"Stolley PD,Tonascia JA,Sartwell PE, et al. (1978) Agreement rates between oral contraceptive users and prescribers in relation to drug use histories. Am J Epidemiol\n107: 226-235.","journal-title":"Am J Epidemiol"},{"key":"5149905_CR31","unstructured":"Cottler LB,Robins LN (1985) The effect of questionnaire design on reported prevalence of psychoactive medication. In: Harris LS, ed. Problems of Drug Dependence, 1984. NIDA Research Monograph 55, pp. 231-237."},{"key":"5149905_CR32","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/oxfordjournals.aje.a115313","volume":"130","author":"SAA Beresford","year":"1989","unstructured":"Beresford SAA,Coker AL (1989) Pictorially assisted recall of past hormone use in case-control studies. Am J Epidemiol\n130: 202-205.","journal-title":"Am J Epidemiol"},{"key":"5149905_CR33","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/oxfordjournals.aje.a114286","volume":"123","author":"AA Mitchell","year":"1986","unstructured":"Mitchell AA,Cottler LB,Shapiro S (1986) Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol\n123: 670-676.","journal-title":"Am J Epidemiol"},{"key":"5149905_CR34","unstructured":"Top 200 Prescription Drugs. http:\/\/rxlist.com\/top200.htm, accessed December 3, 2002."},{"key":"5149905_CR35","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1470-2045(02)00680-0","volume":"3","author":"TA Chan","year":"2002","unstructured":"Chan TA (2002) Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention. Lancet Oncol\n3: 166-174.","journal-title":"Lancet Oncol"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:CACO.0000007973.59863.66.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/B:CACO.0000007973.59863.66\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:CACO.0000007973.59863.66.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T18:33:45Z","timestamp":1750962825000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/B:CACO.0000007973.59863.66"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["5149905"],"URL":"https:\/\/doi.org\/10.1023\/b:caco.0000007973.59863.66","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}